Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome
- PMID: 26172964
- PMCID: PMC8032066
- DOI: 10.1111/jch.12613
Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome
Comment on
-
Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.J Clin Hypertens (Greenwich). 2015 Oct;17(10):777-82. doi: 10.1111/jch.12614. Epub 2015 Jul 14. J Clin Hypertens (Greenwich). 2015. PMID: 26173048 Free PMC article.
Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
The effects of polycystic ovary syndrome on gestational diabetes mellitus.Gynecol Endocrinol. 2016;32(2):139-42. doi: 10.3109/09513590.2015.1101438. Epub 2015 Oct 19. Gynecol Endocrinol. 2016. PMID: 26479686
-
Insulin resistance and sympathetic overactivity in women.J Hypertens. 2006 Jan;24(1):131-41. doi: 10.1097/01.hjh.0000194121.19851.e5. J Hypertens. 2006. PMID: 16331111 Review.
-
Brief review: hypertension in pregnancy : a manifestation of the insulin resistance syndrome?Hypertension. 2001 Feb;37(2):232-9. doi: 10.1161/01.hyp.37.2.232. Hypertension. 2001. PMID: 11230277 Review.
-
Insulin resistance and polycystic ovary syndrome.Curr Diab Rep. 2002 Feb;2(1):71-6. doi: 10.1007/s11892-002-0061-y. Curr Diab Rep. 2002. PMID: 12643125 Review.
Cited by
-
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy.Front Endocrinol (Lausanne). 2019 Aug 23;10:575. doi: 10.3389/fendo.2019.00575. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31507531 Free PMC article. Review.
-
Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.J Clin Hypertens (Greenwich). 2018 Sep;20(9):1313-1318. doi: 10.1111/jch.13351. Epub 2018 Jul 29. J Clin Hypertens (Greenwich). 2018. PMID: 30058103 Free PMC article.
-
Reducing the Risk of Pre-Eclampsia in Women with Polycystic Ovary Syndrome Using a Combination of Pregnancy Screening, Lifestyle, and Medical Management Strategies.J Clin Med. 2024 Mar 20;13(6):1774. doi: 10.3390/jcm13061774. J Clin Med. 2024. PMID: 38541997 Free PMC article. Review.
-
Sodium intake, sodium excretion, and cardiovascular risk: involvement of genetic, hormonal, and epigenetic factors.J Clin Hypertens (Greenwich). 2017 Jul;19(7):650-652. doi: 10.1111/jch.13019. J Clin Hypertens (Greenwich). 2017. PMID: 28692166 Free PMC article. No abstract available.
-
Hypertension in pregnancy: Role of body mass index, insulin resistance, aldosterone, and calcium homeostasis.J Clin Hypertens (Greenwich). 2019 May;21(5):624-626. doi: 10.1111/jch.13538. Epub 2019 Apr 16. J Clin Hypertens (Greenwich). 2019. PMID: 30990242 Free PMC article. No abstract available.
References
-
- Seely EW, Ecker J. Chronic hypertension in pregnancy. N Engl J Med. 2011;365:439–446. - PubMed
-
- Armanini D. Preeclampsia: the role of aldosterone in hypertension and inflammation. Hypertension. 2012;59:1099–1100. - PubMed
-
- Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165–1174. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical